Healthcare and Medicine

Netherlands Artificial Intelligence Tender

📄 Tender ID: 464756671 📅 Published: 17 Aug 2021

📋 Tender Overview

The International Coalition of Medicines Regulatory Authorities ICMRA sets out recommendations to help regulators to address the challenges that the use of artificial intelligence AI poses for global medicines regulation in a report published today.AI includes various technologies such as statistical models diverse algorithms and self-modifying systems that are increasingly being applied across all stages of a medicines lifecycle from preclinical development to clinical trial data recording and analysis to pharmacovigilance and clinical use optimisation. This range of applications brings with it regulatory challenges including the transparency of algorithms and their meaning as well as the risks of AI failures and the wider impact these would have on AI uptake in medicine development and patients health.The report identifies key issues linked to the regulation of future therapies using AI and makes specific recommendations for regulators and stakeholders involved in medicine development to foster the uptake of AI. Some of the main findings and recommendations includeRegulators may need to apply a risk-based approach to assessing and regulating AI which could be informed through exchange and collaboration in ICMRASponsors developers and pharmaceutical companies should establish strengthened governance structures to oversee algorithms and AI deployments that are closely linked to the benefitrisk of a medicinal productRegulatory guidelines for AI development validation and use with medicinal products should be developed in areas such as data provenance reliability transparency and understandability pharmacovigilance and real-world monitoring of patient functioning.The report is based on a horizon-scanning exercise in AI conducted by the ICMRA Informal Network for Innovation working group and led by EMA. The goal of this network is to identify challenging topics for medicine regulators to explore the suitability of existing regulatory frameworks and to develop recommendations to adapt regulatory systems in order to facilitate safe and timely access to innovative medicines.The implementation of the recommendations will be discussed by ICMRA members in the coming months.

🔍 Key Information

📄
Tender Reference No.
464756671
📅
Publication Date
17 Aug 2021
🌐
Sector
Healthcare and Medicine
📝
Notice Type
News
📍
Location
Netherlands

📁 Documents & Downloads

No documents found

🏷️ CPV

No CPV found

Need help with this bid?

Our bid experts can help you find, evaluate & win more tenders.

🎧 Talk to Bid Expert
🕒 Submission deadline
0
days remaining · 17 Aug 2021
🔔 Set Alert

🧭 Quick Facts

Authority N/A
Country Netherlands
State / UT N/A
Tender Type Procurement News
Currency N/A
Similar Tenders
Loading similar tenders…